Transplantation of autologous endothelial progenitor cells

PROCEDURE3 trials

Sponsors

Zhejiang University

Conditions

Idiopathic Pulmonary Arterial Hypertension

Unknown Phase

Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension

CompletedNCT00257413

Zhejiang UniversityIdiopathic Pulmonary Arterial Hypertension

Updated: 2005-11-22

Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension

Zhejiang UniversityIdiopathic Pulmonary Arterial Hypertension

Start: 2006-06-30End: 2007-12-31Target: 40Updated: 2006-09-06

Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension

CompletedNCT00641836

Zhejiang UniversityIdiopathic Pulmonary Arterial Hypertension

Start: 2005-07-31End: 2007-12-31Updated: 2008-03-24

Related Papers

Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial.

2007-03-27214 citations